Measured Context-sensitive Half-times of Remifentanil and Alfentanil
- 1 November 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 83 (5) , 968-975
- https://doi.org/10.1097/00000542-199511000-00009
Abstract
Background: The context-sensitive half-time, rather than the terminal elimination half-life, has been proposed as a more clinically relevant measure of decreasing drug concentration after a constant infusion of a given duration. The context-sensitive half-time is derived from computer modelling using known pharmacokinetic parameters. The modelled context-sensitive half-time for a 3-h infusion of alfentanil is 50–55 min and is 3 min for remifentanil. The terminal elimination half-life is 111 min for alfentanil and 12–30 min for remifentanil. It has not been tested whether the modelled context-sensitive half-time reflects the true time for a 50% decrease in drug concentration or drug effect.Keywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics of Remifentanil (GI87084B) and Its Major Metabolite (GI90291) in Patients Undergoing Elective Inpatient SurgeryAnesthesiology, 1993
- Preliminary Pharmacokinetics and Pharmacodynamics of an Ultra-Short-Acting OpioidAnesthesia & Analgesia, 1993
- The Pharmacokinetics of the New Short-acting Opioid Remifentanil (GI87084B) in Healthy Adult Male VolunteersAnesthesiology, 1993
- Context-sensitive Half-time in MulticompartmentAnesthesiology, 1992
- Pharmacokinetics, Pharmacodynamics, and Rational Opioid SelectionAnesthesiology, 1991
- Pharmacokinetic Model-driven Infusion of FentanylAnesthesiology, 1990
- Depression of Ventilatory Responses to Hypoxia and Hypercapnia After PentamorphoneAnesthesia & Analgesia, 1990
- Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarineClinical Pharmacology & Therapeutics, 1979